Drug induced liver injury secondary to interferon-beta (IFN-β) in multiple sclerosis
Post marketing studies of Interferon-β (IFNβ) therapy in multiple sclerosis (MS) have demonstrated surprisingly high rates of hepatotoxicity. Grade 3 hepatotoxicity (AST and ALT > 5 to 20 upper limit normal) or higher has been observed in as many as 1.4% of MS patients on IFNβ. We report three ca...
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Makale |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
Elsevier
2006-01-01
|
| Seri Bilgileri: | Annals of Hepatology |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S1665268119320435 |